Welcome to the Committee on Energy and Commerce.

E&C is at the forefront of all issues and policies powering America’s economy, including our global competitive edge in energy, technology, and health care.


The Latest

From the Committee

Feb 6, 2025
Press Release
Chairman Carter Delivers Opening Statement at Subcommittee on Health Hearing on Combatting Existing and Emerging Illicit Drug Threats

WASHINGTON, D.C. – Congressman Buddy Carter (GA-01), Chairman of the Subcommittee on Health, delivered the following opening statement at today’s hearing titled Combatting Existing and Emerging Illicit Drug Threats.

"As we gavel in the first Energy and Commerce Subcommittee on Health hearing, American families across the country continue to suffer from failures of the Biden-Harris Administration’s disastrous four years and its inability to address one of the greatest public health threats of our lifetimes: the illicit drugs pouring over our borders. 

"Under the previous Administration, the United States experienced a historic rise of drug overdoses and poisonings, driven by an increased supply of synthetic opioids, such as illicit fentanyl and its analogs.

"Last fiscal year, Customs and Border Protection confiscated over 21,000 pounds of fentanyl at our borders. That is enough fentanyl to kill every American several times over. And that’s just the drugs we know about. 

"Under the Biden-Harris Administration, we saw rates of overdose and poisoning deaths skyrocket, peaking at nearly 108,000 in 2023, driven by the surge of fentanyl coming across our borders. Illicit fentanyl overdoses are now the number one cause of death among adults 18 to 45. Each year, more Americans are dying from illicit fentanyl than the number of American lives lost during the Vietnam War.

"However, I believe we have a great opportunity to make significant and sustainable progress in combating this crisis. To do so we must continue to expand the availability of overdose reversal treatments like naloxone, removing the stigma associated with carrying it and making it as common as a fire extinguisher. Every school in America should have access to naloxone.

"We must secure our borders to stop the scourge of illegal drugs, especially poisons like illicit fentanyl. President Trump has already made progress to address the fentanyl crisis by forcing Mexico and Canada to come to the negotiating table. With President Trump’s leadership, we must continue to crack down on China, Mexico, and anyone who smuggles fentanyl and other synthetic drugs across our borders with the sole intention of preying on Americans. 

"Additionally, this Committee is already taking action to help keep illicit fentanyl out of our communities and save lives. Later today the House will vote on a bill developed by this Committee, the Halt All Lethal Trafficking of Fentanyl Act, which will take the critical step of permanently scheduling all fentanyl-related substances as Schedule I drugs under the Controlled Services Act. 

"These tools and solutions address today’s problem. But, like the evolution of the opioid crisis from the over prescribing of oxycontin to today’s scourge of synthetic opioids like fentanyl, we must prepare for what’s next. In this hearing we’ll hear from our witnesses not just on the illicit drugs threatening our communities today but potential new threats that if left unaddressed will be driving this crisis tomorrow.

"I look forward to hearing that testimony and working alongside my colleagues on addressing these issues."

###


More News & Announcements


Feb 6, 2025
Press Release

Chairmen Guthrie and Carter Applaud Passage of HALT Fentanyl Act

WASHINGTON, D.C. – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman Earl L. “Buddy” Carter (GA-01), Chairman of the Subcommittee on Health, issued the following statement after the House passed H.R. 27, the HALT Fentanyl Act , by a vote of 312 to 108. “As Republicans work to fix the previous Administration’s border crisis and save lives from fentanyl poisoning, this legislation will serve as an important tool for law enforcement to fight against transnational crime organizations and drug smugglers,” said Chairmen Guthrie and Carter . “We are grateful for Reps. Griffith and Latta for their leadership on this legislation and will work with the Senate to see it passed and sent to President Trump’s desk.”   “Today, the House took a critical step forward to combat the fentanyl crisis by passing the HALT Fentanyl Act. For far too long, the Biden administration’s failure to secure our border allowed this deadly drug to pour into our country and kill more than 200 Americans a day. This bill permanently classifies fentanyl-related substances as Schedule I, giving law enforcement the tools needed to halt this epidemic,” said House Speaker Mike Johnson . “With this legislation and President Trump’s recent actions to secure our northern and southern borders, Republicans are taking decisive, strong, and immediate action to keep these dangerous drugs out of our communities.”   “The ongoing fentanyl crisis has been fueled in part by a rise in lethal fentanyl-related substances. We are pleased to see House passage of the HALT Fentanyl Act, which prioritizes the safety of American life and highlights our commitment to defeating the scourge of fentanyl,” said Reps. Griffith and Latta . “Accordingly, we urge swift passage of HALT Fentanyl in the Senate so we can complement President Trump’s actions to curb the flow of fentanyl into America.”   Background:   Drug traffickers are able to exploit loopholes in the criminal code by making minor changes to the chemical composition of fentanyl, creating an “analog” or fentanyl related substances (FRS). Congress granted temporary scheduling authority that allows Drug Enforcement Agency to immediately schedule FRS as a class, removing the incentive for new FRS to be created. The temporary scheduling authority, however, expires in March 2025.  H.R. 27 , the HALT Fentanyl Act , led by Reps. Morgan Griffith (R-VA) and Bob Latta (R-OH), would make the temporary class-wide scheduling order for FRS permanent. It ensures law enforcement have the tools they need to keep these extremely lethal and dangerous drugs off our streets. The bill also ensures practitioners can research fentanyl related substances so we can better understand their overall effects on people's health.  ### 



Feb 6, 2025
Press Release

Law Enforcement and Advocates Urge Passage of HALT Fentanyl Act

WASHINGTON, D.C. —  Law enforcement and advocacy groups are urging Congress to pass H.R. 27, the HALT Fentanyl Act, led by Committee on Energy and Congress Members Reps. Morgan Griffith (VA-09) and Bob Latta (OH-05). Here’s what they have to say: “We commend your early prioritization of this issue and your leadership in pushing this legislation forward. The opioid epidemic continues to claim the lives of hundreds of Americans every day. As this crisis escalates, every delay in addressing it only increases the toll on our communities. For the sake of public safety, it is imperative that the House pass the HALT Fentanyl Act as it stands, without changes, and move it forward to law.” CLICK HERE  to read the letter from the Association of State Criminal Investigative Agencies (ASCIA), Federal Law Enforcement Officers Association (FLEOA), Major Cities Chiefs Association (MCCA), Major County Sheriffs of America (MCSA), National Alliance of State Drug Enforcement Agencies (NASDEA), National Association of Police Organizations (NAPO), National District Attorneys Association (NDAA), National HIDTA Directors Association (NHDA), National Narcotic Officers’ Associations’ Coalition (NNOAC), National Sheriffs’ Association (NSA), Sergeants Benevolent Association NYPD (SBA). “We, the members of the Drug Enforcement Association of Federal Narcotics Agents, are writing to express our strong support for the Halt All Lethal Trafficking (HALT) Fentanyl Act. This bipartisan legislation is crucial in combating the devastating fentanyl crisis that has become the leading cause of death among young adults aged 18-45.” CLICK HERE  to read the letter from Drug Enforcement Association of Federal Narcotics Agents President Marshall Fisher. “The HALT Fentanyl Act is not just about strengthening law enforcement—it is about saving lives and protecting communities. By permanently scheduling fentanyl analogues, we are sending a strong message that the United States will not tolerate the continued destruction caused by this drug.” CLICK HERE  to read the letter from Association of Mature American Citizens Action Chairwoman Rebecca Weber. “On behalf of the National Association of Police Organizations (NAPO), representing over 241,000 sworn law enforcement officers across the United States, I am writing to you to express our strong support for the Halt All Lethal Trafficking of (HALT) Fentanyl Act.  [...] “NAPO has long fought for resources to support law enforcement’s efforts to combat fentanyl, its analogues, and similar opioids. We thank you for your efforts to help the fight against the spread of this deadly poison in our communities and look forward to working with you to pass this important legislation.” CLICK HERE  to read the letter from NAPO Executive Director William J. Johnson. CLICK HERE  to read more about the HALT Fentanyl Act.   ###



Feb 5, 2025
Press Release

Chairmen Guthrie and Bilirakis Announce CMT Subcommittee Hearing on Advanced Manufacturing

WASHINGTON, D.C.  – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman Gus Bilirakis (FL-12), Chairman of the Subcommittee on Commerce, Manufacturing, and Trade, announced a hearing titled  AI in Manufacturing: Securing American Leadership in Manufacturing and the Next Generation of Technologies. “Our country’s rich manufacturing history has been a cornerstone of the American economy, driving entrepreneurship, job creation, and economic growth. New consumer-facing artificial intelligence applications have captured the public imagination, but the development and deployment of enterprise AI technologies has also transformed manufacturing in recent years. By fostering innovation, strengthening supply chains, and promoting a skilled workforce, we can secure American leadership in the next generation of manufacturing,”   said Chairmen Guthrie and Bilirakis.   “We look forward to rolling up our sleeves alongside workers in these industries to build a foundation for the next great American manufacturing revolution.” Subcommittee on Commerce, Manufacturing, and Trade hearing titled  AI in Manufacturing: Securing American Leadership in Manufacturing and the Next Generation of Technologies. WHAT : Subcommittee on Commerce, Manufacturing, and Trade hearing addressing technology in manufacturing. DATE : Wednesday, February 12, 2025 TIME : 10:00 AM ET LOCATION : 2123 Rayburn House Office Building This notice is at the direction of the Chairmen. The hearing will be open to the public and press and will be live streamed online at  https://energycommerce.house.gov.  If you have any questions concerning the hearing, please contact Alex Khlopin with the Committee staff at  Alex.Khlopin@mail.house.gov . If you have any press-related questions, please contact Daniel Kelly at  Daniel.Kelly@mail.house.gov . ###


Trending Subcommittees

Commerce, Manufacturing, and Trade


3 Updates

Interstate and foreign commerce, including all trade matters within the jurisdiction of the full committee; consumer protection, including privacy matters generally; data security; motor vehicle safety; regulation of commercial practices (the Federal Trade Commission), including sports-related matters; consumer product safety (the Consumer Product Safety Commission); product liability; and regulation of travel, tourism, and time. The Subcommittee’s jurisdiction can be directly traced to Congress’ constitutional authority “to regulate Commerce with foreign nations, and among the several States, and with the Indian Tribes.”


Communications & Technology


6 Updates

Electronic communications, both Interstate and foreign, including voice, video, audio and data, whether transmitted by wire or wirelessly, and whether transmitted by telecommunications, commercial or private mobile service, broadcast, cable, satellite, microwave, or other mode; technology generally; emergency and public safety communications; cybersecurity, privacy, and data security; the Federal Communications Commission, the National Telecommunications and Information Administration, the Office of Emergency Communications in the Department of Homeland Security; and all aspects of the above-referenced jurisdiction related to the Department of Homeland Security.


Energy


4 Updates

National Energy Policy, energy infrastructure and security, energy related Agencies and Commissions, all laws, programs, and government activities affecting energy matters. National Energy Policy focuses on fossil energy; renewable energy; nuclear energy; energy conservation, utility issues, including but not limited to interstate energy compacts; energy generation, marketing, reliability, transmission, siting, exploration, production, efficiency, cybersecurity, and ratemaking for all generated power. Energy infrastructure and security focuses on pipelines, the strategic petroleum reserve, nuclear facilities, and cybersecurity for our nation’s grid. Our jurisdiction also includes all aspects of the above-referenced jurisdiction related to the Department of Homeland Security. Agencies and Commissions in our jurisdiction include: The US Department of Energy, the Nuclear Regulatory Commission; and the Federal Energy Regulatory Commission.


Recent Letters


Jan 6, 2025
Press Release

Chairman Guthrie and Chairman Latta Question Energy Department’s Involvement in Biden-Harris Offshore Drilling Ban

WASHINGTON, D.C.  – Yesterday, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, along with Congressman Bob Latta (OH-05), Chairman of the Subcommittee on Energy, penned a letter to Secretary Jennifer Granholm questioning the Department of Energy’s involvement in the Biden-Harris Administration’s decision to prevent new offshore oil and gas production, leading to higher prices for consumers and harming U.S. energy security. KEY LETTER EXCERPT: “Closing off swaths of U.S. offshore areas to energy production, as the Biden-Harris Administration reportedly intends to do, will lead to higher energy prices for American families, the loss of American jobs, and greatly diminish our country’s energy security. As the Secretary of Energy, you have an obligation to weigh in on this matter and insist on a full review of the energy security and economic impacts before any decisions are finalized. “The United States stands at an energy crossroads, facing mounting global security threats and soaring demand for power. Instead of leading the world in energy production, we’ve allowed misguided “green” policies to hamstring our potential. It’s time to unleash American energy dominance again—the federal government must become an ally, not an obstacle, to our nation’s energy security. We look forward to your prompt response to this request, no later than January 10, 2025.” Read the story  here . BACKGROUND: This morning, the Biden Administration announced that more than 625 million square miles of coastline would be off-limits for energy production. Republican Members of the House Committee on Energy and Commerce have continuously called on the Biden-Harris Administration to end its attack on American energy production before leaving office on January 20th. The letter requests an explanation of the DOE’s involvement in the decision and whether the White House or the Department of Interior consulted with the DOE about the plans to close off access to offshore resources. Any decision to shut down access to significant American energy resources impacts U.S. energy policy and should be reviewed by the DOE. The Biden Administration’s energy policies have continued to create major harm to America’s energy production and workforce. A unilateral ban on energy production in large swaths of the U.S. coastline will have lasting impacts on American energy production and security.



Dec 19, 2024
Press Release

E&C Republicans Request HHS Watchdog Investigate Promotion of Gender Transition Procedures for Children

Washington, D.C. — In a new letter to Department of Health and Human Services (HHS) Inspector General Christi Grimm, House Energy and Commerce Committee Republicans requested an investigation into the strength, quality, and types of evidence-based scientific and pediatric medical literature relied on by the department to promote gender transition procedures for children.  KEY LETTER EXCERPT:  “As the agency responsible for safeguarding the health and well-being of Americans, all of HHS’s medical treatment recommendations, especially medical treatment recommendations for children, should be based on rigorous and well-established research, such as randomized controlled trials, that have definitively illustrated the long-term benefits of gender affirming care treatments.”  BACKGROUND:  Under the Biden administration, HHS has advocated for sex reassignment procedures on minors, including the use of serum puberty blockers, which have historically been used to treat children with precocious puberty (i.e., early onset puberty affecting about one percent of U.S. children) and sex offenders.   Puberty blockers, however, are known to stunt normal childhood development in children unaffected by precocious puberty.  HHS officials contend that sex reassignment procedures on minors are an unanimously accepted medical practice.  HHS Secretary Becerra testified before Congress that “every major medical association,” “medical journals,” and “scientific and medical evidence” has demonstrated the benefits of transitioning children’s biological sex.  When asked, via a Freedom of Information Act request, for the underlying scientific or medical basis for its position, HHS was only able to produce a two-page brochure that was already publicly available.  In contrast to HHS, a growing body of literature from medical experts and authorities around the world, including those in Europe, caution against performing such procedures on minors.   Courts and government health agencies responsible for determining child welfare have sought to limit child sex reassignment procedures.   Other countries have banned these interventions and surgeries on minors altogether.  An article published in the British Journal of Medicine found “there is great uncertainty about the effects of puberty blockers, cross-sex hormones, and surgeries in young people.”   A court in the United Kingdom noted the obvious about administering puberty blocking chemicals onto children: “[i]t is highly unlikely that a child aged 13 or under would be competent to give consent to the administration of puberty blockers. It is doubtful that a child aged 14 or 15 could understand and weigh the long-term risks and consequences of the administration of puberty blockers.”  In April 2024, the Cass Review , an independent review of gender identity services for children and young people, commissioned by the National Health Service England, found “[w]hile a considerable amount of research has been published in this field, systematic evidence reviews demonstrated the poor quality of the published studies, meaning there is not a reliable evidence base upon which to make clinical decisions, or for children and their families to make informed choices.”   The Cass Review also found that “[t]he rationale for early puberty suppression remains unclear, with weak evidence regarding the impact on gender dysphoria, mental or psychosocial health,” as well as unknown effects on cognitive and psychosexual development.  In August 2024, the American Society of Plastic Surgeons (ASPS) became the first major U.S. medical association to express caution on the use of gender surgery for gender dysphoria in adolescents. In its formal statement, the association stated: “ASPS currently understands that there is considerable uncertainty as to the long-term efficacy for the use of chest and genital surgical interventions for the treatment of adolescents with gender dysphoria, and the existing evidence base is viewed as low quality/low certainty. This patient population requires specific considerations.”   The letter was signed by Committee Chair Cathy McMorris Rodgers (R-WA), Subcommittee on Health Chair Brett Guthrie (R-KY), Subcommittee on Oversight and Investigations Chair Morgan Griffith (R-VA), Rep. Dan Crenshaw (R-TX), Rep. Gus Bilirakis (R-FL), Rep. Buddy Carter (R-GA), Rep. Gary Palmer (R-AL), Rep. Neal Dunn (R-FL), Rep. Randy Weber (R-TX), Rep. Troy Balderson (R-OH), Rep. August Pfluger (R-TX), Rep. Diana Harshbarger (R-TN), and Rep. Kat Cammack (R-FL).  CLICK HERE to read the letter.



Nov 22, 2024
Press Release

E&C, E&W Republicans Press Gladstone Institutes for Information Regarding Internal Antisemitism

House Republicans scrutinize government grant funding recipients that fail to protect individuals from antisemitism Washington, D.C. — In a new letter to J. David Gladstone Institutes President Dr. Deepak Srivastava, the House Committee on Energy and Commerce (E&C) and House Committee on Education and the Workforce (E&W) have requested information about ongoing and pervasive acts of antisemitic harassment and intimidation at Gladstone and its leadership’s insufficient response to these acts. The letter is signed by E&C Chair Cathy McMorris Rodgers (R-WA), E&C Subcommittee on Health Chair Brett Guthrie (R-KY), E&C Oversight and Investigations Subcommittee Chair Morgan Griffith (R-VA), E&W Chair Virginia Foxx (R-NC), and E&W Subcommittee on Higher Education and Workforce Development Chair Burgess Owens (R-UT).  KEY LETTER EXCERPTS: “The Gladstone Institutes, an independent biomedical research organization, claims that it takes an active stance against serious issues like discrimination and harassment and aims to ‘ensure all community members at Gladstone feel included’ and that the Institutes will aim to ‘implement accountability measures and reinforce Gladstone’s commitment to having an environment free of harassment.’ However, these values do not seem to be reflected in the actions of leadership in response to recent concerns of antisemitic harassment and discrimination within the Institutes.” [...] “The reports of antisemitic harassment at Gladstone coupled with the inadequate response by leadership is concerning to the Committees. Failing to act decisively to ensure a safe environment for all trainees, faculty, and staff is a grave dereliction of your responsibilities as President of Gladstone.” “Failing to comply with basic safety protections for members of Gladstone or failure to respond appropriately to and prevent harassment and discrimination, no matter the cause, may be grounds to withhold federal funds from the university. Congress has an obligation to exercise oversight of recipients of federal funds when blatant and ongoing Title VI violations appear to be happening. If Congress determines an institution of higher education/research is blatantly ignoring its legal responsibilities, we may consider rescinding research and development funds previously appropriated.” BACKGROUND ON TAXPAYER FUNDING: Gladstone received more than $41 million in funding from the NIH in Fiscal Year 2023, not including potential taxpayer funding that individual faculty may have received through their affiliation with the University of California, San Francisco (UCSF) or any other affiliated universities.   According to the NIH’s Grant Policy Statement, any institution receiving federal funds must assure work environments are free of discriminatory harassment and are safe and conducive to high-quality work.  Institutions receiving federal taxpayer financial assistance—such as NIH grants—are prohibited from discriminating based on a variety of categories, including national origin.   These laws also protect members of the institution who are or are perceived to be members of a group with shared ancestry, such as students/trainees of Jewish heritage. BACKGROUND ON INSTANCES OF ANTISEMITISM : Two days after the October 7, 2023, Hamas terrorist attack, a graduate student working in a lab within Gladstone sent an antisemitic email to all Gladstone faculty, trainees, and staff falsely stating that the attack on innocent Israeli civilians was “the resistance in Gaza launch[ing] a surprise attack against Israel, taking occupation soldiers hostage, taking over Israeli military vehicles, and gain[ing] control over illegal Israeli settlements.”  The email goes on to claim that all casualties resulting from Palestinian actions are the responsibility of Israel.  Immediately following this mass email, members of the Gladstone faculty began contacting the Gladstone Institutes’ President and other leadership, appalled by the language of the email, concerned for their safety and worried that the email could be seen as an incitement to violence.  Jewish members of the Institutes also expressed their deep, personal pain following the Hamas attack, as some members had family or friends reported killed or missing directly after the attack.  These fears—including fears of being attacked in the lab by the author of this cruel and antagonistic email—were shared directly with President Srivastava.  Despite this, Gladstone leadership did not issue a public statement or position against antisemitism to quell fears of Jewish faculty and trainees.  In May 2024, the Center for Combatting Antisemitism sent President Srivastava a letter requesting administrative action to address the hostile environment and disparate treatment of Jewish members at Gladstone.  This letter noted that Gladstone refused to acknowledge Jewish American Heritage Month, Passover, or Holocaust Remembrance Day, despite sending official celebratory emails and holding events for other religious, ethnic, or national holidays, including Black History Month, International Women’s Day, and Ramadan.  The Center followed up with Gladstone several times, but never received a response.  Jewish faculty and trainees have conveyed to leadership within Gladstone instances of antisemitic harassment and discrimination, which faculty and trainees believe were not taken seriously, making some feel uneasy about speaking out.  For example, per a publicly available Fair Employment and Housing Act complaint to the California Civil Rights Division, a Jewish faculty member openly discussed fellow faculty using racial stereotypes, including comments about a “Jewish nose.”  When these comments were brought to human resources, no investigation occurred.  Instead, the complainant was subsequently targeted with an investigation ultimately deemed to be unwarranted.  Then, following the complainant’s post-October 7th advocacy on behalf of Jewish faculty and trainees, the complainant was threatened repeatedly with career-ending termination, allegedly in an attempt to extort a resignation.  When the threats did not have their desired effect, Gladstone placed the complainant on administrative leave and removed the complainant’s electronic access to email and files but also physical access to the complainant’s lab, removing all ability to conduct work on an NIH-funded grant.  Gladstone ultimately paid an undisclosed sum to settle the matter and avoid litigation.  To elevate concerns regarding widespread, ongoing discrimination, Jewish faculty and trainees requested permission to bring in a speaker related to antisemitism.  Other minority groups had previously been given permission to bring in similar anti-racism speakers.  However, while leadership stated it would look into the idea, ultimately no speaker was brought, and no program was launched regarding antisemitism. BACKGROUND ON AFFILIATIONS WITH OTHER INSTITUTIONS UNDER INVESTIGATION : Gladstone Institutes is affiliated with other institutions under congressional investigation.  For example, Gladstone is an affiliate of the UCSF, which is undergoing congressional investigation for reports of antisemitism within the university, medical school, and medical centers.  Most of Gladstone’s principal investigators are also faculty at UCSF, and the Institutes provide research positions and opportunities for graduate students from UCSF.  Moreover, there is a joint institute—the Gladstone-UCSF Institute of Genomic Immunology—further linking the two institutions.  Gladstone is also affiliated with the University of California, Berkeley and Stanford University, both of which are also under investigation for concerns related to antisemitism. CLICK HERE to read the full letter.